Related Experiment Video
Updated: Oct 17, 2025

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
Published on: August 6, 2015
Negative feedback of SNRK to circ-SNRK regulates cardiac function post-myocardial infarction
Zhi-Yan Wang1, Xiao-Xiao Liu2, Yun-Fei Deng3
1Department of cardiovascular medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
A novel circular RNA, circ-SNRK, enhances cardiac mitochondrial efficiency by regulating the miR-33/SNRK axis. This circRNA shows therapeutic potential for heart failure by improving cardiac function post-myocardial infarction.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- RNA Biology
Background:
- Myocardial infarction (MI) impairs cardiac function, often leading to heart failure due to reduced oxygen and substrate delivery.
- Cardiac mitochondrial efficiency is crucial for maintaining heart function and energy metabolism.
Purpose of the Study:
- To identify novel regulatory mechanisms of cardiac energy metabolism in response to ischemia.
- To investigate the role of circular RNAs in the pathophysiology of heart failure post-MI.
Main Methods:
- Identification and characterization of circ-SNRK in cardiomyocytes (CMs).
- Investigation of the circ-SNRK interaction with miR-33 and SNRK (sucrose nonfermenting 1-related kinase).
- Analysis of NOVA1 (NOVA alternative splicing regulator 1) involvement in circ-SNRK formation.
- In vivo studies using rat models of myocardial infarction.
Main Results:
- Circ-SNRK sponges miR-33, enhancing ATP synthesis via SNRK, establishing a circ-SNRK-miR-33-SNRK axis.
- A negative feedback loop involving SNRK cleavage, nuclear entry, and NOVA1 binding inhibits circ-SNRK formation.
- Overexpression of exogenous circ-SNRK improved cardiac function in rats post-MI, breaking the inhibitory loop.
Conclusions:
- The circ-SNRK/SNRK negative feedback loop regulates cardiomyocyte (CM) energy metabolism.
- Circ-SNRK represents a potential therapeutic target for heart failure by modulating cardiac energy metabolism.
Abstract:
A limited delivery of oxygen and metabolic substrate to the heart caused by myocardial infarction (MI) impairs the cardiac function, and often results in heart failure. Here, we identified a circRNA (circ-SNRK) from SNRK (sucrose nonfermenting 1-related kinase, which can increase the cardiac mitochondrial efficiency) in cardiomyocytes (CMs). Circ-SNRK can sponge the miR-33 and in turn improved the ATP synthesis via SNRK, proving the existence of circ-SNRK - miR-33 - SNRK axis. Furthermore, we found that protein NOVA1 (NOVA alternative splicing regulator 1) could accelerate the circ-SNRK formation; a cleaved peptide (~55 kDa) from SNRK enters the nucleus and blocks the cyclization of circ-SNRK via binding to NOVA1. The aforementioned negative feedback of SNRK to circ-SNRK limited the SNRK at a proper level, and inhibited the protective role of circ-SNRK in ischemic heart. In addition, our in vivo experiment indicated that the overexpression of exogenic circ-SNRK could break this loop and improves the cardiac function post-MI in rats. Together, our results demonstrated that the negative loop of circ-SNRK with SNRK regulates the energy metabolism in CMs, thus might be a potential therapeutic target for heart failure.
More Related Videos
08:01Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Cardiac Performance
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure